Ria Health Raises Growth Capital to Accelerate Access to Patient-Driven AUD Treatment
Summary
GREENWICH, Conn., March 06, 2025--(BUSINESS WIRE)--Ria Health ("Ria" or the "Company"), a leading telehealth provider of evidence-based alcohol use disorder (AUD) treatment, today announced the closing of a Series B growth equity round led by Peloton Equity, LLC ("Peloton"), with participation from existing investors including SV Health Investors ("SV"), BPEA Private Equity, and SOSV.The Company will use the new capital to continue scaling its clinical model and payor coverage, accelerate investments in sales and marketing, and enhance Rias differentiated position as a value-add partner in the continuum of AUD care.Ria delivers AUD treatment nationally, rooted in an evidence-based clinical model that combines medication assisted treatment, behavioral therapy, and coaching. The Companys industry leading outcomes are driven by a physician-led clinical team and a program designed to meet patients where they are seeking either harm reduction or abstinence from alcohol. "Rias value-based payor arrangements align incentives around improvements in key quality metrics and a phased approach to service utilization. "Rias business model and AUD-focused clinical program produce unparalleled access to specialized, cost-effective treatment and incredible patient outcomes," said Michael ORourke. "The Company has already demonstrated strong momentum on the path to transforming the AUD treatment industry, and we look forward to supporting its continued innovation and growth."